Zhejiang Xianju Pharmaceutical Co., Ltd. (002332.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 8.55

From 52W high−23.06%

Volume6.68M

Market capCNY 8.35B

P/E (TTM)18.6x

P/S (TTM)2.3x

Div yield4.68%

Key dataSep 18, 2026

Open

CNY 8.55

From 52W high

−23.06%

Volume

6.68M

Market cap

CNY 8.35B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

10.7x

P/E (TTM)

18.6x

RSI (14)

47.2

MomentumView details →

1D Return

+0.00%

YTD Return

−5.11%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

18.6x

EV/EBITDA

10.7x

EV/Sales

2.0x

P/S (TTM)

2.3x

P/B (TTM)

1.4x

ProfitabilityView details →

Gross Margin

62.36%

Net Margin

10.89%

EBITDA Margin

18.89%

ROE (TTM)

6.57%

ROA (TTM)

5.50%

Asset Turnover

0.51x

GrowthView details →

Revenue YoY

−7.60%

EPS YoY

+2.18%

FCF YoY

+156.73%

Revenue CAGR 3Y

−4.97%

EPS CAGR 3Y

−15.94%

EBITDA YoY

—

MomentumView details →

1D Return

+0.00%

YTD Return

−5.11%

1Y Return

−14.76%

RSI (14)

47.2

vs 50D SMA

−0.28%

vs 200D SMA

−3.21%

Capital & dividendView details →

Debt/Equity

0.02x

Current Ratio

3.32x

Quick Ratio

2.43x

Div Yield

4.68%

Div Rate

CNY 0.40

Div Growth 1Y

−25.00%

EarningsView details →

EPS (Actual)

CNY 0.15

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

−1.06%

Financials snapshotView financials →

Revenue (TTM)

3.67B

Net Income (TTM)

399.54M

Op. CF (TTM)

363.84M

Next earningsOct 22, 2026 →

Latest newsMore news →

Xianju Hongju Microfinance Co., Ltd., a 30%-owned associate of Zhejiang Xianju Pharmaceutical, plans to apply to regulators to exit the microfinance business and its shareholders intend to reduce capital pro rata after approval.11d ago

Zhejiang Cuize Pharmaceutical Technology plans to increase registered capital by 420,264 yuan, subscribed by Zhejiang Zizi Xian'an Yaoxin Equity Investment Partnership (Limited Partnership) for 20 million yuan in cash, while Xianju Pharmaceutical waived its preferential subscription right, reducing its stake from 32.1957% to 31.4512%.11d ago

Similar companies

博苑新材301617.SZ 北摩高科002985.SZ 宏源药业301246.SZ 上大股份301522.SZ 科陆电子002121.SZ 湘潭电化002125.SZ Find similar companies →

Latest newsMore news →

Xianju Hongju Microfinance Co., Ltd., a 30%-owned associate of Zhejiang Xianju Pharmaceutical, plans to apply to regulators to exit the microfinance business and its shareholders intend to reduce capital pro rata after approval.11d ago Zhejiang Cuize Pharmaceutical Technology plans to increase registered capital by 420,264 yuan, subscribed by Zhejiang Zizi Xian'an Yaoxin Equity Investment Partnership (Limited Partnership) for 20 million yuan in cash, while Xianju Pharmaceutical waived its preferential subscription right, reducing its stake from 32.1957% to 31.4512%.11d ago